免疫血液學市場規模、佔有率和成長分析（按產品、最終用途、技術和地區分類）－2026-2033年產業預測

預計到 2024 年，免疫血液學市場規模將達到 20.1 億美元，到 2025 年將達到 21 億美元，到 2033 年將達到 30.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 4.63%。

受技術進步和創新產品推出的推動，免疫血液學市場預計將迎來顯著成長。醫院和研究機構的一個顯著趨勢是轉向使用自動化設備，以提升營運效率，並採用多功能平台。白血病、貧血和各種出血性疾病等血液相關疾病發生率的上升，推動了對高效血液檢測的需求。研發投入的大幅增加、醫療政策的強化以及政府的支持性政策，以及其他因素，進一步提振了產業前景。此外，大量評估自動化免疫血液學檢查設備準確性和有效性的研究證實，需要精準的診斷方法來應對日益增多的血液疾病，確保市場在不久的將來持續強勁成長。

免疫血液學市場促進因素

全球免疫血液學市場的主要促進因素之一是血友病、地中海貧血和鐮狀貧血等血液疾病的日益普遍，這些疾病需要先進的血液檢測和輸血管理。對安全且相容的血液製品的需求不斷成長，推動了尖端免疫血液學技術的發展，從而有助於改善患者照護和治療效果。此外，擇期手術和創傷相關手術的增加也進一步推動了對高效輸血服務的需求。隨著醫療系統致力於提高輸血的安全性和有效性，免疫血液學領域的創新也不斷推動市場擴張和投資。

免疫血液學市場限制因素

影響全球免疫血液學市場的關鍵限制因素之一是嚴格的血液安全和產品核可監管環境。這些監管程序的複雜性和冗長性會減緩新技術和創新成果的引入，從而抑制該領域的投資和研發。此外，不同地區的監管差異會使國際公司進入市場更加複雜，導致營運成本增加和市場分散。這些障礙會阻礙整體市場成長，限制先進免疫血液學產品和服務的獲取，進而影響醫療機構及時有效地提供輸血和診斷解決方案的能力。

免疫血液學市場趨勢

免疫血液學市場正呈現出一個顯著的趨勢，即開發和應用專注於個人化醫療和學名藥的先進技術。關鍵創新包括改進罕見血型抗原的檢測方法，這些方法最佳化了輸血通訊協定，並實現了根據患者個體特徵量身定做的輸血。這項轉變得益於基因分型和分子診斷技術研發投入的增加，這些技術能夠揭示複雜的血型模式。隨著醫療保健向精準醫療發展，這些進步不僅改善了患者的治療效果，還簡化了輸血流程，為免疫血液學領域的顯著成長和發展奠定了基礎，使其能夠不斷演進以滿足動態的臨床需求。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術分析
• 監管環境
• 專利分析
• PESTEL 分析
• 案例研究分析

免疫血液學市場：依產品分類

• 免疫血液分析儀
• 免疫血液學試劑

免疫血液學市場：依最終用途分類

• 醫院
• 血庫
• 診斷檢查室

免疫血液學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• Grifols
• QuidelOrtho
• Immucor
• Bio-Rad Laboratories
• Beckman Coulter
• Novartis
• Quotient Limited
• Diagast
• Becton, Dickinson and Company
• Thermo Fisher Scientific
• Abbott Laboratories
• BioMerieux
• Hologic, Inc.
• Werfen SA
• Merck KGaA
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Immucor Gamma Biologics
• Tulip Diagnostics Pvt. Ltd.
• Versiti

Immunohematology Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.1 Billion in 2025 to USD 3.02 Billion by 2033, growing at a CAGR of 4.63% during the forecast period (2026-2033).

The immunohematology market is poised for substantial growth, propelled by technological advancements and innovative product launches. A notable trend among hospitals and research institutions is the transition to automated instrumentation, with a preference for multifunctional platforms that streamline operations. The rising incidence of blood-related disorders, including leukemia, anemia, and various hemorrhagic diseases, fuels the demand for efficient hematological testing. Significant increases in research and development funding, along with enhanced healthcare initiatives and favorable government policies, further bolster industry prospects. Additionally, extensive research assessing the accuracy and efficacy of automated immunohematology analyzers underscores the necessity for precise diagnostics in addressing the escalating prevalence of blood disorders, ultimately positioning the market for robust expansion in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunohematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunohematology Market Segments Analysis

Global Immunohematology Market is segmented by Product, End Use, and region. Based on Product , the market is segmented into Immunohematology analyzer, Immunohematology reagent. Based on End Use, the market is segmented into Hospitals, Blood banks, Diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunohematology Market

One of the key market drivers for the global immunohematology market is the increasing prevalence of blood disorders, such as hemophilia, thalassemia, and sickle cell anemia, which necessitate advanced blood testing and transfusion practices. The rising demand for safe and compatible blood products has led to the development of sophisticated immunohematology techniques, enhancing patient care and outcomes. Additionally, the growth in elective surgeries and trauma-related procedures further drives the requirement for efficient blood transfusion services. As healthcare systems focus on improving the safety and efficacy of blood transfusions, innovations in immunohematology continue to propel market expansion and investment.

Restraints in the Immunohematology Market

One significant restraint affecting the global immunohematology market is the stringent regulatory landscape governing blood safety and product approval processes. The complexity and length of these regulatory procedures can delay the introduction of new technologies and innovations, discouraging investment and development in the sector. Additionally, varying regulations across regions can complicate market entry for international companies, resulting in increased operational costs and potential market fragmentation. These barriers can hinder overall market growth and limit access to advanced immunohematology products and services, affecting healthcare providers' ability to deliver timely and effective blood transfusion and diagnostic solutions.

Market Trends of the Immunohematology Market

The immunohematology market is witnessing a notable trend towards the development and adoption of advanced technologies focusing on personalized medicine and generic medications. Key innovations include enhanced methodologies for detecting rare blood group antigens, ultimately refining blood transfusion protocols to better match individual patient profiles. This shift is supported by increased investments in research and development of genotyping and molecular diagnostics that elucidate intricate blood group patterns. As healthcare moves towards precision medicine, these advancements not only improve patient outcomes but also streamline transfusion processes, positioning the immunohematology sector for significant growth and evolution in response to dynamic clinical needs.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Technology Analysis
• Regulatory Landscape
• Patent Analysis
• PESTEL Analysis
• Case Study Analysis

Immunohematology Market, By Product

• Market Overview
• Immunohematology analyzer
• Immunohematology reagent

Immunohematology Market, By End Use

• Market Overview
• Hospitals
• Blood banks
• Diagnostic laboratories

Immunohematology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagast
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor Gamma Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Versiti
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments